Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,655Revenue (TTM) $M1,045Net Margin (%)-46.2Altman Z-Score7.1
Enterprise Value $M14,296EPS (TTM) $-3.0Operating Margin %-58.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-61.8Higher ROA y-yN
Price/Book5.510-y EBITDA Growth Rate %--Quick Ratio3.5Cash flow > EarningsY
Price/Sales13.35-y EBITDA Growth Rate %--Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-13.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-20.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M172ROIC % (ttm)-19.6Gross Margin Increase y-yN

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMRNGeorge Soros 2016-09-30 Buy 0.02%$79.86 - $101.46
($94.17)
$ 85.21-10%New holding5,734
BMRNJoel Greenblatt 2016-09-30 Sold Out $79.86 - $101.46
($94.17)
$ 85.21-10%Sold Out0
BMRNJoel Greenblatt 2016-06-30 Buy $74.61 - $93.8
($84.98)
$ 85.210%New holding3,144
BMRNJoel Greenblatt 2015-06-30 Sold Out $112.05 - $140
($123.93)
$ 85.21-31%Sold Out0
BMRNJoel Greenblatt 2015-03-31 Buy $90.28 - $129.14
($105.95)
$ 85.21-20%New holding4,195
BMRNJoel Greenblatt 2014-12-31 Sold Out $67.27 - $94.19
($83.42)
$ 85.212%Sold Out0
BMRNJoel Greenblatt 2014-09-30 Buy $55.78 - $73
($65.82)
$ 85.2129%New holding3,885
BMRNMeridian Funds 2013-06-30 Sold Out -0.09%$54.72 - $70.3
($62.32)
$ 85.2137%Sold Out0
BMRNMeridian Funds 2013-03-31 Reduce-0.17%$49.2 - $62.39
($56.51)
$ 85.2151%Reduce -69.03%40,700
BMRNMeridian Funds 2012-12-31 Reduce-0.3%$36.78 - $50.17
($45.59)
$ 85.2187%Reduce -60.99%131,400
BMRNGeorge Soros 2012-06-30 Sold Out -0.15%$32.53 - $38.87
($36.01)
$ 85.21137%Sold Out0
BMRNGeorge Soros 2012-03-31 Add0.11%$33.68 - $38.34
($32.99)
$ 85.21158%Add 300.00%300,000
BMRNGeorge Soros 2011-12-31 Reduce-0.05%$30.07 - $35.38
($32.81)
$ 85.21160%Reduce -57.14%75,000
BMRNGeorge Soros 2011-06-30 Add0.07%$24.93 - $28.455
($26.32)
$ 85.21224%Add 862.36%191,510
BMRNMeridian Funds 2011-03-31 Reduce-0.28%$23.46 - $28.29
($25.46)
$ 85.21235%Reduce -51.54%348,800
BMRNGeorge Soros 2011-03-31 Buy 0.01%$23.46 - $28.29
($25.46)
$ 85.21235%New holding19,900
BMRNGeorge Soros 2010-09-30 Sold Out -0.02%$18.24 - $23.09
($20.93)
$ 85.21307%Sold Out0
BMRNMeridian Funds 2010-03-31 Add0.13%$18.75 - $23.81
($20.92)
$ 85.21307%Add 20.83%795,900
BMRNGeorge Soros 2010-03-31 Add$18.75 - $23.81
($20.92)
$ 85.21307%Add 35.87%30,300
BMRNGeorge Soros 2009-12-31 Buy 0.01%$15.49 - $18.98
($17.17)
$ 85.21396%New holding22,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMRN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIENAIME JEAN JACQUESCEO 2017-01-11Sell8,000$90.58-5.93view
BIENAIME JEAN JACQUESCEO 2017-01-09Sell8,000$88.49-3.71view
SPIEGELMAN DANIEL KEVP, CFO 2017-01-09Sell5,000$90-5.32view
BIENAIME JEAN JACQUESCEO 2016-12-30Sell8,000$83.61.93view
FUCHS HENRY JPresident, Worldwide R&D 2016-11-25Sell15,000$87.4-2.51view
BIENAIME JEAN JACQUESCEO 2016-11-22Sell139,487$86.62-1.63view
Davis George EricEVP, General Counsel 2016-11-18Sell5,000$90.42-5.76view
BIENAIME JEAN JACQUESCEO 2016-11-16Sell41,670$90.97-6.33view
SPIEGELMAN DANIEL KEVP, CFO 2016-11-09Sell20,000$90.61-5.96view
LAWLIS V BRYANDirector 2016-11-09Sell7,500$95-10.31view

Press Releases about BMRN :

Quarterly/Annual Reports about BMRN:

News about BMRN:

Articles On GuruFocus.com
Piotroski F-Score in the Real World Dec 19 2016 
U.S. Elections: What They Might Mean for Investors - JOHCM Commentary Nov 29 2016 
Low Valuation Ratios Lead to Strong Portfolio Returns Sep 13 2016 
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter Jul 29 2016 
Roche Holdings Definitely Not a Lumbering Giant Jul 11 2016 
Spiros Segalas Buys McDonald's, Microsoft, Alibaba May 05 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
J.P. Morgan’s 3 Biotechnology Picks Apr 14 2015 
You Can No Longer Ignore Biotech Feb 07 2014 
Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 

More From Other Websites
BioMarin CEO: Positive results for hemophilia treatment Jan 09 2017
BioMarin Pharma cites positive results for hemophilia treatment Jan 08 2017
BioMarin to Provide Update to Proof-of-Concept Data for BMN 270 Gene Therapy in Hemophilia A at 35th... Jan 08 2017
Could Sanofi Acquire BioMarin In Wake Of Amgen LDL Brouhaha? Jan 06 2017
Blog Coverage Affimed Join Hands with MD Anderson Cancer Center for Clinical Immuno-Oncology... Jan 05 2017
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin... Jan 04 2017
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bullish Manner : BMRN-US :... Jan 04 2017
3 Overlooked Drug Stocks to Watch Out for in 2017 Jan 03 2017
BioMarin to Present at 35th Annual J.P. Morgan Healthcare Conference in San Francisco Jan 03 2017
BioMarin (BMRN) Raised to Buy: Should You Add the Stock? Dec 29 2016
Time for biotech to boom ... or bust? Dec 27 2016
RBC Likes Large Cap Biotech Leaders for 2017 Dec 22 2016
BioMarin Pharmaceutical, Inc. – Value Analysis (NASDAQ:BMRN) : December 21, 2016 Dec 21 2016
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bearish Manner : BMRN-US :... Dec 20 2016
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change... Dec 19 2016
Will Insurers Pay For Sarepta's DMD Drug? Dec 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)